Sort   by:  
 Page size 
UnknownIndividualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration.
Not available
S-EPMC6938544 | biostudies-literature
UnknownA systematic evidence map for the evaluation of noncancer health effects and exposures to polychlorinated biphenyl mixtures.
Not available
S-EPMC10013199 | biostudies-literature
UnknownClinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration.
Not available
S-EPMC6988137 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownAssessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.
Not available
S-EPMC6842665 | biostudies-literature
UnknownLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Not available
S-EPMC8822604 | biostudies-literature
UnknownGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977 | biostudies-literature
Sort   by:  
 Page size